M&A Deal Summary |
|
|---|---|
| Date | 2016-07-18 |
| Target | DiaMedica |
| Sector | Life Science |
| Buyer(s) | Hermed Capital Co. |
| Deal Type | Going Private |
| Deal Value | 4M USD |
SEARCH BY
Hermed Capital is a private investment firm focused on the healthcare sector. Specific areas of interest include pharmaceuticals, medical devices & diagnostics, and medical services. Hermed Capital was formed in 2015 and is headquartered in Shanghai
| DEAL STATS | # |
|---|---|
| Overall | 3 of 6 |
| Sector: Life Science M&A | 2 of 4 |
| Type: Going Private M&A Deals | 1 of 1 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 3 of 5 |
| Year: 2016 M&A | 2 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-06-06 |
Applied StemCell
Milpitas, California, United States Applied StemCell is a biotechnology company providing optimized tools and platforms for basic research, drug discovery, bioprocessing, bioproduction, and preclinical applications. Applied StemCell was established in 2008 and is based in Milpitas, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-04-28 |
Epic Sciences
San Diego, California, United States Epic Sciences is a developer of novel diagnostics to personalize and advance the treatment and management of cancer. Epic’s mission is to enable the rapid and non-invasive detection of genetic and molecular changes in cancer throughout a patient’s journey. Epic Sciences was founded in 2008 and is based in San Diego, California. |
Buy | - |
